Replimune Group, Inc. (REPL)

8.07 +1.03 (+14.63%) USD  |  NASDAQ  |  Mar 06, 16:00
9.21 +1.14 (+14.13%) After-Hours: 20:00
More

Replimune Group Price to Book Value (3y Mean)

Price to Book Value (3y Mean) Chart

View Price to Book Value (3y Mean) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Value (3y Mean) Range, Past 5 Years

View Price to Book Value (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value (3y Mean) Benchmarks

View Price to Book Value (3y Mean) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade